Friday February 24th 2017: C. R. Bard, Inc., BCR is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, C. R. Bard, Inc., BCR has a market cap of 23.39 B. Since its IPO date on the 04/06/1983, C. R. Bard, Inc., BCR performance year to date is 42.46%. Today C. R. Bard, Inc., BCR has gained 0.00%, with a current price of 320.04.
Ownership of the company is 0.40% for insider ownership while institutional ownership is 89.70%. The management of the company have seen the company have a payout ratio of 12.70%. Return of assets are at 11.20%, with return on investment at 17.30%.
In terms of debt levels and profit levels, C. R. Bard, Inc., BCR is seeing a long-term debt/equity of 0.68. While Total debt/equity is 1.05. With a profit margin of 15.60%, this is combined with a gross margin of 62.80%, and operating margin of 20.60%. C. R. Bard, Inc. ability to meet debt levels, with a current ratio of 1.5, while the quick ratio is 1.2.
For the last year C. R. Bard, Inc., BCR has seen a EPS growth of 297.20%. A performance for the year of 36.25%. The 52-week high is -0.01%, and the 52-week low is 57.17%. The average volume for C. R. Bard, Inc., BCR is 0.
With a target price of 305.08, can C. R. Bard, Inc., BCR reach this target? Looking at the value indicators of C. R. Bard, Inc., BCR. C. R. Bard, Inc. has a P/E of 40.69 and a forward P/E of 24.78. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.55. C. R. Bard, Inc. also has a P/S and a P/B of 6.19 and 13.99 respectively. For P/cash, C. R. Bard, Inc. has a value of 26.27, while it is 56.76 for P/free cash flow.
At the current price of 320.04, C. R. Bard, Inc. has a dividend yield of 0.32%. We see a return on equity of 35.30%.
Looking more long-term C. R. Bard, Inc., is projected to get an EPS growth for the next five years of 11.46%. In the short-term an EPS growth of 9.61% in the next year is forecasted. This is after a EPS growth of 297.20% for this year and for the last five years a 13.80% growth has been seen.